Data showing that DLL1+ BC tumor cells display CSC characteristics [20], together with our findings showing that DLL1 controls the expression of SOX9, supports the importance of these studies, which may provide additional insights into the mechanisms underlying DLL1’s key oncogenic role in BC. The gene discussed is SOX9; the disease is breast cancer.